Your session is about to expire
← Back to Search
Hormone Therapy
Growth Hormone for Traumatic Brain Injury
Phase < 1
Waitlist Available
Research Sponsored by University of Virginia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
Study Summary
The purpose of this study is to look at the relationship between growth hormones, and recovery from a TBI - traumatic brain injury. It is believed that a TBI may interfere with the body's ability to produce growth hormones. These hormones may be needed by the body for growth, mental development and sexual maturation.
Eligible Conditions
- Traumatic Brain Injury
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Neurocognitive changes following moderate/severe TBI
Trial Design
1Treatment groups
Experimental Treatment
Group I: Growth HormoneExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Somatotropin
FDA approved
Find a Location
Who is running the clinical trial?
Virginia Commonwealth UniversityOTHER
696 Previous Clinical Trials
22,885,086 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,694 Previous Clinical Trials
6,952,497 Total Patients Enrolled
University of VirginiaLead Sponsor
753 Previous Clinical Trials
1,245,023 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger